M. G. Whiteside

2.2k total citations
34 papers, 402 citations indexed

About

M. G. Whiteside is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. G. Whiteside has authored 34 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Genetics and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. G. Whiteside's work include Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). M. G. Whiteside is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). M. G. Whiteside collaborates with scholars based in Australia, Canada and United Kingdom. M. G. Whiteside's co-authors include David Cowling, Maurizio Macaluso, Douglas C. Heimburger, Gary L. Johanning, Chandrika J. Piyathilake, Anna R. Giuliano, Merran B. Smith, Kathy McGrath, N. F. Coghill and A. Wynn Williams and has published in prestigious journals such as Cancer, Gut and British Journal of Haematology.

In The Last Decade

M. G. Whiteside

33 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. G. Whiteside Australia 10 163 125 66 65 58 34 402
Nomie A. Shore United States 11 129 0.8× 46 0.4× 46 0.7× 59 0.9× 66 1.1× 28 380
Khaled Alsaeid Kuwait 14 56 0.3× 191 1.5× 55 0.8× 52 0.8× 34 0.6× 34 431
Ayşen Timurağaoğlu Türkiye 9 130 0.8× 28 0.2× 65 1.0× 49 0.8× 82 1.4× 21 415
I. Rákóczi Hungary 10 101 0.6× 31 0.2× 26 0.4× 66 1.0× 30 0.5× 22 402
Manuela Goycoolea Chile 9 390 2.4× 71 0.6× 86 1.3× 62 1.0× 99 1.7× 15 567
William J. Baker United States 9 78 0.5× 37 0.3× 14 0.2× 106 1.6× 21 0.4× 33 294
Ünsal Günay Türkiye 9 145 0.9× 24 0.2× 37 0.6× 40 0.6× 116 2.0× 17 407
G. Barbiano di Belgioioso Italy 7 122 0.7× 90 0.7× 52 0.8× 38 0.6× 35 0.6× 10 565
Werasak Sasanakul Thailand 14 267 1.6× 43 0.3× 117 1.8× 28 0.4× 157 2.7× 58 487
D Belghiti France 10 85 0.5× 43 0.3× 68 1.0× 35 0.5× 106 1.8× 28 353

Countries citing papers authored by M. G. Whiteside

Since Specialization
Citations

This map shows the geographic impact of M. G. Whiteside's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Whiteside with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Whiteside more than expected).

Fields of papers citing papers by M. G. Whiteside

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Whiteside. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Whiteside. The network helps show where M. G. Whiteside may publish in the future.

Co-authorship network of co-authors of M. G. Whiteside

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Whiteside. A scholar is included among the top collaborators of M. G. Whiteside based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Whiteside. M. G. Whiteside is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piyathilake, Chandrika J., Maurizio Macaluso, Gary L. Johanning, et al.. (2000). Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.. PubMed. 20(3A). 1751–7. 83 indexed citations
2.
Seymour, JF, et al.. (1994). An effective age‐unrestricted m‐AMSA‐based second‐line regimen for poor prognosis acute myeloid leukaemia. European Journal Of Haematology. 52(2). 80–86. 5 indexed citations
3.
Whiteside, M. G., et al.. (1988). TREATMENT OF HAIRY CELL LEUKEMIA WITH INCREASING DOSES OF RECOMBINANT ALPHA A INTERFERON. Australian and New Zealand Journal of Medicine. 18(4). 557–562. 1 indexed citations
4.
Bishop, James F., D. Joshua, Ray M. Lowenthal, et al.. (1986). A PHASE Ml STUDY OF CYTOSINE ARABINOSIDE, DAUNORUBICIN, AND VP16–213 IN ADULT PATIENTS WITH ACUTE NON‐LYMPHOCYTIC LEUKEMIA. Australian and New Zealand Journal of Medicine. 16(1). 48–51. 19 indexed citations
5.
Weyden, Martin B Van Der, et al.. (1984). The Biochemical and Clinical Consequences of 2′‐Deoxycoformycin in T Cell Chronic Lymphocytic Leukaemia. Scandinavian Journal of Haematology. 32(1). 55–64. 7 indexed citations
6.
Ackland, Stephen P., James F. Bishop, & M. G. Whiteside. (1983). Acyclovir therapy in patients with malignant disease and disseminated herpes zoster. The Medical Journal of Australia. 1(13). 637–638. 2 indexed citations
7.
Brodie, G. N., et al.. (1979). Erythroleukemia following drug induced hypoplastic anemia. Cancer. 44(6). 2140–2146. 10 indexed citations
8.
Bishop, James F., et al.. (1977). THE MANAGEMENT OF FEBRILE EPISODES IN • NEUTROPENIC CANCER PATIENTS. The Medical Journal of Australia. 1(14). 473–476. 2 indexed citations
9.
Whiteside, M. G., et al.. (1976). IMMUNOTHERAPY WITH CHEMOTHERAPY IN THE MAINTENANCE OF REMISSION IN ACUTE MYELOBLASTIC LEUKAEMIA. The Medical Journal of Australia. 2(1). 10–13. 1 indexed citations
10.
Smith, Merran B. & M. G. Whiteside. (1975). THE DETECTION OF GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENCY IN MEDITERRANEANS BY COMPARATIVE QUANTITATIVE ENZYME ELECTROPHORESIS. The Medical Journal of Australia. 1(18). 558–559. 4 indexed citations
11.
Whiteside, M. G.. (1975). Platelets: Production, Function, Transfusion, and Storage. The Medical Journal of Australia. 2(20). 777–777. 40 indexed citations
12.
Smith, Merran B., et al.. (1975). An Investigation of the Complications and Outcome of Pregnancy in Heterozygous Beta‐Thalassaemia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 15(1). 26–30. 1 indexed citations
13.
Foy, Aidan, M.N. Cauchi, & M. G. Whiteside. (1975). Non-specific immunological function in acute myeloblastic leukaemia. Pathology. 7(2). 117–123. 2 indexed citations
14.
Smith, Merran B. & M. G. Whiteside. (1974). THE DETECTION OF HETEROZYGOUS GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENCY IN MEDITERRANEANS BY COMPARATIVE ENZYME ASSAY. The Medical Journal of Australia. 1(5). 133–135. 5 indexed citations
15.
Whiteside, M. G. & Merran B. Smith. (1973). HETEROZYGOUS BETA‐THALASSEMIA IN PREGNANCY. The Medical Journal of Australia. 2(10). 487–490. 3 indexed citations
16.
Whiteside, M. G., et al.. (1964). The absorption of radioactive vitamin B 12 and the secretion of hydrochloric acid in patients with atrophic gastritis. Gut. 5(5). 385–399. 34 indexed citations
17.
Whiteside, M. G. & B Ungár. (1963). MEGALOBLASTIC ANÆMIA DUE TO VITAMIN B12DEFICIENCY PROBABLY PRECIPITATED BY SEVERE BLOOD LOSS. The Medical Journal of Australia. 1(17). 618–621. 3 indexed citations
18.
Watson, D.A., et al.. (1962). THE DIAGNOSIS OF FOLIC ACID DEFICIENCY: PRELIMINARY COMMUNICATION. The Medical Journal of Australia. 1(9). 326–327. 1 indexed citations
19.
Whiteside, M. G.. (1960). THE DILUTION ANÆMIA OF PREGNANCY. The Medical Journal of Australia. 2(8). 284–287. 9 indexed citations
20.
Whiteside, M. G.. (1954). PHAEOCHROMOCYTOMA OF THE SUPRARENAL GLAND. The Medical Journal of Australia. 2(19). 748–753. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026